Cargando…

Glycyrrhizin for treatment of CRS caused by CAR T-cell therapy: A pharmacological perspective

Chimeric antigen receptor T (CAR T)-cell therapy promises to revolutionize the management of hematologic malignancies and possibly other tumors. However, the main side effect of cytokine release syndrome (CRS) is a great challenge for its clinical application. Currently, treatment of CRS caused by C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Xingxing, Li, Juan, Luo, Pan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009180/ https://www.ncbi.nlm.nih.gov/pubmed/36923358 http://dx.doi.org/10.3389/fphar.2023.1134174

Ejemplares similares

Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19
por: Luo, Pan, et al.
Publicado: (2020)

Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy
por: Pan, Jing, et al.
Publicado: (2020)

Investigation of CRS-associated cytokines in CAR-T therapy with meta-GNN and pathway crosstalk
por: Wei, Zhenyu, et al.
Publicado: (2022)

How I treat refractory CRS and ICANS after CAR T-cell therapy
por: Jain, Michael D., et al.
Publicado: (2023)

The Pharmacological Activities of Glycyrrhizinic Acid (“Glycyrrhizin”) and Glycyrrhetinic Acid
por: Graebin, Cedric Stephan
Publicado: (2017)

Macrophage, the potential key mediator in CAR-T related CRS
por: Hao, Zhaonian, et al.
Publicado: (2020)

Research Progress on the Antiviral Activity of Glycyrrhizin and its Derivatives in Liquorice
por: Huan, Changchao, et al.
Publicado: (2021)

Micro-simulation insights into the functional and mechanistic understanding of glycyrrhizin against asthma
por: Qi, Jian-Hong, et al.
Publicado: (2023)

Identification of an Alternative Glycyrrhizin Metabolite Causing Liquorice-Induced Pseudohyperaldosteronism and the Development of ELISA System to Detect the Predictive Biomarker
por: Ishiuchi, Kan'ichiro, et al.
Publicado: (2021)

Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
por: Niu, Min, et al.
Publicado: (2022)

Corrigendum: Identification of an alternative glycyrrhizin metabolite causing liquorice-induced pseudohyperaldosteronism and the development of ELISA system to detect the predictive biomarker
por: Ishiuchi, Kan’ichiro, et al.
Publicado: (2022)

The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions
por: Li, Yanping, et al.
Publicado: (2022)

Glycyrrhizin Ameliorate Ischemia Reperfusion Lung Injury through Downregulate TLR2 Signaling Cascade in Alveolar Macrophages
por: Fei, Lin, et al.
Publicado: (2017)

Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling
por: Li, Yun, et al.
Publicado: (2021)

Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS
por: Masucci, Chiara, et al.
Publicado: (2023)

P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY
por: Yokoyama, Shota, et al.
Publicado: (2023)

Protective Effects of Magnesium Glycyrrhizinate on Methotrexate-Induced Hepatotoxicity and Intestinal Toxicity May Be by Reducing COX-2
por: Cao, Yuzhu, et al.
Publicado: (2019)

Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells
por: Wei, Zhenyu, et al.
Publicado: (2023)

A novel glycyrrhizin acid-coated stent reduces neointimal formation in a rabbit iliac artery model
por: Teng, Shuai, et al.
Publicado: (2023)

Assessment and predictive ability of the absolute neutrophil count in peripheral blood for in vivo CAR T cells expansion and CRS
por: Zhang, Man, et al.
Publicado: (2023)

Glycyrrhizin arginine salt protects against cisplation-induced acute liver injury by repressing BECN1-mediated ferroptosis
por: Guo, Jun, et al.
Publicado: (2023)

Therapeutic Potential of TNFα and IL1β Blockade for CRS/ICANS in CAR-T Therapy via Ameliorating Endothelial Activation
por: Chen, Yunshuo, et al.
Publicado: (2021)

Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome
por: Lakomy, Tim, et al.
Publicado: (2023)

Tibetan Medicine for Diabetes Mellitus: Overview of Pharmacological Perspectives
por: Yan, Li-Shan, et al.
Publicado: (2021)

CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
por: Li, Weizhen, et al.
Publicado: (2021)

CAR T-Cell Therapies in Italy: Patient Access Barriers and Recommendations for Health System Solutions
por: Jommi, Claudio, et al.
Publicado: (2022)

Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives
por: Roseman, Leor, et al.
Publicado: (2022)

A literature perspective on the pharmacological applications of yohimbine
por: Jabir, Nasimudeen R., et al.
Publicado: (2022)

Targeting HMGB1-NFκb Axis and miR-21 by Glycyrrhizin: Role in Amelioration of Corneal Injury in a Mouse Model of Alkali Burn
por: Wang, Peihong, et al.
Publicado: (2022)

Identification of the Mechanism of Matrine Combined with Glycyrrhizin for Hepatocellular Carcinoma Treatment through Network Pharmacology and Bioinformatics Analysis
por: Han, Tao, et al.
Publicado: (2022)

Pharmacological Benefits of Triphala: A Perspective for Allergic Rhinitis
por: Jantrapirom, Salinee, et al.
Publicado: (2021)

Advantages and applications of CAR-expressing natural killer cells
por: Glienke, Wolfgang, et al.
Publicado: (2015)

Wenxin Keli for the Treatment of Arrhythmia—Systems Pharmacology and In Vivo Pharmacological Assessment
por: Li, Xiaofeng, et al.
Publicado: (2021)

A Model Perspective Explanation of the Long-Term Sustainability of a Fully Human BCMA-Targeting CAR (CT103A) T-Cell Immunotherapy
por: Mu, Wei, et al.
Publicado: (2022)

Uterine fibroids — Causes, impact, treatment, and lens to the African perspective
por: Sefah, Narvella, et al.
Publicado: (2023)

Systems Pharmacology-Based Strategy to Investigate Pharmacological Mechanisms of Radix Puerariae for Treatment of Hypertension
por: Wu, Wenting, et al.
Publicado: (2020)

Pharmacological Treatment of Secondary Lymphedema
por: Brown, Stav, et al.
Publicado: (2022)

Studying GPCR/cAMP pharmacology from the perspective of cellular structure
por: Wright, Peter T., et al.
Publicado: (2015)

Therapeutics of Charcot neuroarthropathy and pharmacological mechanisms: A bone metabolism perspective
por: Liu, Liang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fkp3602hdhevaps37nenj8a3dp